The CIC-backed clinical genomics platform operator took its series B round to $30.1m following a $17.1m extension that will fund the development of automation and statistical analysis functionality.

VTT and the EIF will anchor Voima Ventures’ fund, which is aiming to raise $56.1m to invest in deep tech businesses based on science and research from the Nordics and Baltics.

On-demand courier platform Glovo has collected $168m from investors including Papa John’s franchisee Drake to bring its total funding to more than $344m.

Cambridge Enterprise and CIC featured in cancer therapy developer PolyProx Therapeutics’ seed round, which will coommercialise research from the university’s pharmacology department.

UCL bowel cancer diagnostics spinout Odin Vision has attracted the UCL Technology Fund in a round that will support trials of its first computer vision-powered product.

Bpifrance and HTGF are among the investors for Alentis Therapeutics’ series A round, proceeds of which will support the development of a therapy for liver fibrosis and cancer.

Spun out of University of Nantes and research institute Inserm, GoLiver Therapeutics hopes to catalyse a stem cell-based regenerative drug candidate for the treatment of acute and chronic severe liver failure.

Dicronis hopes its microneedle-based device will help clinicians catch impairments in cancer patients’ lymphatic network that cause chronic swelling in the legs, arm of chest.

Cambridge Innovation Capital is in line for an exit as oncology drug developer Bicycle Therapeutics prepares to float, having filed to raise $86m in its IPO.

More than six years after being launched by Open University to offer massive open online courses, FutureLearn has raised its first external funding from Seek Group.